See more : Netel Holding AB (publ) (NETEL.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Shanrong Biotechnology Corp. (SRBT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanrong Biotechnology Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Direct Selling Acquisition Corp. (DSAQ-WT) Income Statement Analysis – Financial Results
- Nakabohtec Corrosion Protecting Co.,Ltd. (1787.T) Income Statement Analysis – Financial Results
- Jackson Financial Inc. (JXN-PA) Income Statement Analysis – Financial Results
- Venlon Enterprises Limited (VENLONENT.BO) Income Statement Analysis – Financial Results
- Ace Ethanol LLC (ACEEU) Income Statement Analysis – Financial Results
Shanrong Biotechnology Corp. (SRBT)
Industry: Shell Companies
Sector: Financial Services
About Shanrong Biotechnology Corp.
Shanrong Biotechnology Corp. operates as a project management and executive consulting company. The company refurbishes and upgrades armored vehicles with digital communications, as well as provides spare parts and equipment for military and police forces; and offers onsite maintenance, maintenance training, operator training, and tactical training services. It also conducts program management, business development, and strategic studies and analyses in the defense, homeland security, information technology, and telecommunications markets. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Beverly Hills, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.32M | 692.47K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.32M | 692.47K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.07K | 2.07K | 6.10M | 3.07M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.40K | 78.99K | 0.00 | 0.00 | 0.00 | 223.41K | 31.75K | 28.33K | 2.07K | 2.07K | 6.10M | 3.07M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 223.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 16.40K | 78.99K | 0.00 | 0.00 | 0.00 | 446.83K | 31.75K | 28.33K | 2.07K | 2.07K | 6.13M | 3.11M |
| Cost & Expenses | 16.40K | 78.99K | 0.00 | 0.00 | 0.00 | 446.83K | 31.75K | 28.33K | 2.07K | 2.07K | 6.13M | 3.11M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 270.20K | 306.72K |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 2.07K | 2.07K | 35.62K | 35.60K |
| EBITDA | -16.40K | -78.99K | 0.00 | 0.00 | 0.00 | -446.83K | -31.75K | -28.33K | 0.00 | 0.00 | -4.77M | -2.38M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -360.27% | -343.46% |
| Operating Income | -16.40K | -78.99K | 0.00 | 0.00 | 0.00 | -446.83K | -31.75K | -28.33K | -2.07K | -2.07K | -4.81M | -2.41M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -362.96% | -348.60% |
| Total Other Income/Expenses | -1.00 | 7.00 | 0.00 | 0.00 | 0.00 | 223.38K | -3.00 | 3.00 | 3.00 | 0.00 | -269.67K | -305.93K |
| Income Before Tax | -16.40K | -78.98K | 0.00 | 0.00 | 0.00 | -223.44K | -31.75K | -28.33K | -2.07K | -2.07K | -5.08M | -2.72M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -383.32% | -392.78% |
| Income Tax Expense | -167.90K | -228.49K | 0.00 | 0.00 | 0.00 | -223.44K | -52.52K | -22.82K | -2.07K | 0.00 | 270.20K | 306.72K |
| Net Income | -16.40K | -78.98K | 0.00 | 0.00 | 0.00 | 0.00 | -31.75K | -28.33K | -2.07K | -2.07K | -5.08M | -2.72M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -383.32% | -392.78% |
| EPS | -0.03 | -0.16 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 | -8.55 |
| EPS Diluted | -0.03 | -0.16 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 | -8.55 |
| Weighted Avg Shares Out | 484.85K | 484.85K | 2.98M | 2.98M | 2.98M | 2.98M | 2.98M | 1.84M | 484.80K | 484.00K | 0.00 | 317.96K |
| Weighted Avg Shares Out (Dil) | 484.85K | 484.85K | 2.98M | 2.98M | 2.98M | 2.98M | 2.98M | 1.84M | 484.80K | 484.81K | 0.00 | 317.96K |
Source: https://incomestatements.info
Category: Stock Reports